The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urological Medications Market Research Report 2025
Synopsis
Urological Medications are drugs used in the treatment of urogenital conditions and diseases such as SUI,BPH,OAB and ED.
The global Urological Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urological Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urological Medications.
Report Scope
The Urological Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urological Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urological Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viatris
Pfizer
Merck
Astellas Pharma
Abbott
ADVANZ PHARMA
GlaxoSmithKline
Bayer HealthCare Pharmaceuticals
Novartis
Piramal Pharma Solutions
Endo International
Sanofi-aventis U.S. LLC
AbbVie
Mallinckrodt
Lilly
Segment by Type
Alpha Blockers
5-Alpha Inhibitors
Anticholinergics
Others
Segment by Application
SUI
BPH
OAB
ED
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urological Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Urological Medications are drugs used in the treatment of urogenital conditions and diseases such as SUI,BPH,OAB and ED.
The global Urological Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urological Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urological Medications.
Report Scope
The Urological Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urological Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urological Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viatris
Pfizer
Merck
Astellas Pharma
Abbott
ADVANZ PHARMA
GlaxoSmithKline
Bayer HealthCare Pharmaceuticals
Novartis
Piramal Pharma Solutions
Endo International
Sanofi-aventis U.S. LLC
AbbVie
Mallinckrodt
Lilly
Segment by Type
Alpha Blockers
5-Alpha Inhibitors
Anticholinergics
Others
Segment by Application
SUI
BPH
OAB
ED
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urological Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urological Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alpha Blockers
1.2.3 5-Alpha Inhibitors
1.2.4 Anticholinergics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urological Medications Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SUI
1.3.3 BPH
1.3.4 OAB
1.3.5 ED
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urological Medications Market Perspective (2019-2030)
2.2 Urological Medications Growth Trends by Region
2.2.1 Global Urological Medications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Urological Medications Historic Market Size by Region (2019-2024)
2.2.3 Urological Medications Forecasted Market Size by Region (2025-2030)
2.3 Urological Medications Market Dynamics
2.3.1 Urological Medications Industry Trends
2.3.2 Urological Medications Market Drivers
2.3.3 Urological Medications Market Challenges
2.3.4 Urological Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urological Medications Players by Revenue
3.1.1 Global Top Urological Medications Players by Revenue (2019-2024)
3.1.2 Global Urological Medications Revenue Market Share by Players (2019-2024)
3.2 Global Urological Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Urological Medications Revenue
3.4 Global Urological Medications Market Concentration Ratio
3.4.1 Global Urological Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urological Medications Revenue in 2023
3.5 Urological Medications Key Players Head office and Area Served
3.6 Key Players Urological Medications Product Solution and Service
3.7 Date of Enter into Urological Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urological Medications Breakdown Data by Type
4.1 Global Urological Medications Historic Market Size by Type (2019-2024)
4.2 Global Urological Medications Forecasted Market Size by Type (2025-2030)
5 Urological Medications Breakdown Data by Application
5.1 Global Urological Medications Historic Market Size by Application (2019-2024)
5.2 Global Urological Medications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Urological Medications Market Size (2019-2030)
6.2 North America Urological Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Urological Medications Market Size by Country (2019-2024)
6.4 North America Urological Medications Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urological Medications Market Size (2019-2030)
7.2 Europe Urological Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Urological Medications Market Size by Country (2019-2024)
7.4 Europe Urological Medications Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urological Medications Market Size (2019-2030)
8.2 Asia-Pacific Urological Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Urological Medications Market Size by Region (2019-2024)
8.4 Asia-Pacific Urological Medications Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urological Medications Market Size (2019-2030)
9.2 Latin America Urological Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Urological Medications Market Size by Country (2019-2024)
9.4 Latin America Urological Medications Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urological Medications Market Size (2019-2030)
10.2 Middle East & Africa Urological Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Urological Medications Market Size by Country (2019-2024)
10.4 Middle East & Africa Urological Medications Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viatris
11.1.1 Viatris Company Detail
11.1.2 Viatris Business Overview
11.1.3 Viatris Urological Medications Introduction
11.1.4 Viatris Revenue in Urological Medications Business (2019-2024)
11.1.5 Viatris Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Urological Medications Introduction
11.2.4 Pfizer Revenue in Urological Medications Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Urological Medications Introduction
11.3.4 Merck Revenue in Urological Medications Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Urological Medications Introduction
11.4.4 Astellas Pharma Revenue in Urological Medications Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Urological Medications Introduction
11.5.4 Abbott Revenue in Urological Medications Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 ADVANZ PHARMA
11.6.1 ADVANZ PHARMA Company Detail
11.6.2 ADVANZ PHARMA Business Overview
11.6.3 ADVANZ PHARMA Urological Medications Introduction
11.6.4 ADVANZ PHARMA Revenue in Urological Medications Business (2019-2024)
11.6.5 ADVANZ PHARMA Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Urological Medications Introduction
11.7.4 GlaxoSmithKline Revenue in Urological Medications Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Bayer HealthCare Pharmaceuticals
11.8.1 Bayer HealthCare Pharmaceuticals Company Detail
11.8.2 Bayer HealthCare Pharmaceuticals Business Overview
11.8.3 Bayer HealthCare Pharmaceuticals Urological Medications Introduction
11.8.4 Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2019-2024)
11.8.5 Bayer HealthCare Pharmaceuticals Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Urological Medications Introduction
11.9.4 Novartis Revenue in Urological Medications Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Piramal Pharma Solutions
11.10.1 Piramal Pharma Solutions Company Detail
11.10.2 Piramal Pharma Solutions Business Overview
11.10.3 Piramal Pharma Solutions Urological Medications Introduction
11.10.4 Piramal Pharma Solutions Revenue in Urological Medications Business (2019-2024)
11.10.5 Piramal Pharma Solutions Recent Development
11.11 Endo International
11.11.1 Endo International Company Detail
11.11.2 Endo International Business Overview
11.11.3 Endo International Urological Medications Introduction
11.11.4 Endo International Revenue in Urological Medications Business (2019-2024)
11.11.5 Endo International Recent Development
11.12 Sanofi-aventis U.S. LLC
11.12.1 Sanofi-aventis U.S. LLC Company Detail
11.12.2 Sanofi-aventis U.S. LLC Business Overview
11.12.3 Sanofi-aventis U.S. LLC Urological Medications Introduction
11.12.4 Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2019-2024)
11.12.5 Sanofi-aventis U.S. LLC Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Detail
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Urological Medications Introduction
11.13.4 AbbVie Revenue in Urological Medications Business (2019-2024)
11.13.5 AbbVie Recent Development
11.14 Mallinckrodt
11.14.1 Mallinckrodt Company Detail
11.14.2 Mallinckrodt Business Overview
11.14.3 Mallinckrodt Urological Medications Introduction
11.14.4 Mallinckrodt Revenue in Urological Medications Business (2019-2024)
11.14.5 Mallinckrodt Recent Development
11.15 Lilly
11.15.1 Lilly Company Detail
11.15.2 Lilly Business Overview
11.15.3 Lilly Urological Medications Introduction
11.15.4 Lilly Revenue in Urological Medications Business (2019-2024)
11.15.5 Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Urological Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Alpha Blockers
Table 3. Key Players of 5-Alpha Inhibitors
Table 4. Key Players of Anticholinergics
Table 5. Key Players of Others
Table 6. Global Urological Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Urological Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Urological Medications Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Urological Medications Market Share by Region (2019-2024)
Table 10. Global Urological Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Urological Medications Market Share by Region (2025-2030)
Table 12. Urological Medications Market Trends
Table 13. Urological Medications Market Drivers
Table 14. Urological Medications Market Challenges
Table 15. Urological Medications Market Restraints
Table 16. Global Urological Medications Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Urological Medications Market Share by Players (2019-2024)
Table 18. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2023)
Table 19. Ranking of Global Top Urological Medications Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Urological Medications Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Urological Medications Product Solution and Service
Table 23. Date of Enter into Urological Medications Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Urological Medications Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Urological Medications Revenue Market Share by Type (2019-2024)
Table 27. Global Urological Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Urological Medications Revenue Market Share by Type (2025-2030)
Table 29. Global Urological Medications Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Urological Medications Revenue Market Share by Application (2019-2024)
Table 31. Global Urological Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Urological Medications Revenue Market Share by Application (2025-2030)
Table 33. North America Urological Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Urological Medications Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Urological Medications Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Urological Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Urological Medications Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Urological Medications Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Urological Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Urological Medications Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Urological Medications Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Urological Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Urological Medications Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Urological Medications Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Urological Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Urological Medications Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Urological Medications Market Size by Country (2025-2030) & (US$ Million)
Table 48. Viatris Company Detail
Table 49. Viatris Business Overview
Table 50. Viatris Urological Medications Product
Table 51. Viatris Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 52. Viatris Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Urological Medications Product
Table 56. Pfizer Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Urological Medications Product
Table 61. Merck Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Astellas Pharma Company Detail
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Urological Medications Product
Table 66. Astellas Pharma Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 67. Astellas Pharma Recent Development
Table 68. Abbott Company Detail
Table 69. Abbott Business Overview
Table 70. Abbott Urological Medications Product
Table 71. Abbott Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. ADVANZ PHARMA Company Detail
Table 74. ADVANZ PHARMA Business Overview
Table 75. ADVANZ PHARMA Urological Medications Product
Table 76. ADVANZ PHARMA Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 77. ADVANZ PHARMA Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Urological Medications Product
Table 81. GlaxoSmithKline Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Bayer HealthCare Pharmaceuticals Company Detail
Table 84. Bayer HealthCare Pharmaceuticals Business Overview
Table 85. Bayer HealthCare Pharmaceuticals Urological Medications Product
Table 86. Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 87. Bayer HealthCare Pharmaceuticals Recent Development
Table 88. Novartis Company Detail
Table 89. Novartis Business Overview
Table 90. Novartis Urological Medications Product
Table 91. Novartis Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Piramal Pharma Solutions Company Detail
Table 94. Piramal Pharma Solutions Business Overview
Table 95. Piramal Pharma Solutions Urological Medications Product
Table 96. Piramal Pharma Solutions Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 97. Piramal Pharma Solutions Recent Development
Table 98. Endo International Company Detail
Table 99. Endo International Business Overview
Table 100. Endo International Urological Medications Product
Table 101. Endo International Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 102. Endo International Recent Development
Table 103. Sanofi-aventis U.S. LLC Company Detail
Table 104. Sanofi-aventis U.S. LLC Business Overview
Table 105. Sanofi-aventis U.S. LLC Urological Medications Product
Table 106. Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 107. Sanofi-aventis U.S. LLC Recent Development
Table 108. AbbVie Company Detail
Table 109. AbbVie Business Overview
Table 110. AbbVie Urological Medications Product
Table 111. AbbVie Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 112. AbbVie Recent Development
Table 113. Mallinckrodt Company Detail
Table 114. Mallinckrodt Business Overview
Table 115. Mallinckrodt Urological Medications Product
Table 116. Mallinckrodt Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 117. Mallinckrodt Recent Development
Table 118. Lilly Company Detail
Table 119. Lilly Business Overview
Table 120. Lilly Urological Medications Product
Table 121. Lilly Revenue in Urological Medications Business (2019-2024) & (US$ Million)
Table 122. Lilly Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urological Medications Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Urological Medications Market Share by Type: 2023 VS 2030
Figure 3. Alpha Blockers Features
Figure 4. 5-Alpha Inhibitors Features
Figure 5. Anticholinergics Features
Figure 6. Others Features
Figure 7. Global Urological Medications Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Urological Medications Market Share by Application: 2023 VS 2030
Figure 9. SUI Case Studies
Figure 10. BPH Case Studies
Figure 11. OAB Case Studies
Figure 12. ED Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Urological Medications Report Years Considered
Figure 16. Global Urological Medications Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Urological Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Urological Medications Market Share by Region: 2023 VS 2030
Figure 19. Global Urological Medications Market Share by Players in 2023
Figure 20. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Urological Medications Revenue in 2023
Figure 22. North America Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Urological Medications Market Share by Country (2019-2030)
Figure 24. United States Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Urological Medications Market Share by Country (2019-2030)
Figure 28. Germany Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Urological Medications Market Share by Region (2019-2030)
Figure 36. China Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Urological Medications Market Share by Country (2019-2030)
Figure 44. Mexico Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Urological Medications Market Share by Country (2019-2030)
Figure 48. Turkey Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Viatris Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 52. Merck Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 53. Astellas Pharma Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 54. Abbott Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 55. ADVANZ PHARMA Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 57. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 58. Novartis Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 59. Piramal Pharma Solutions Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 60. Endo International Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 61. Sanofi-aventis U.S. LLC Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 62. AbbVie Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 63. Mallinckrodt Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 64. Lilly Revenue Growth Rate in Urological Medications Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
